Skull scan signal was higher in secondary progressive MS
Key Takeaway
A skull scan signal was higher in secondary progressive MS and was linked to greater disability.
What They Found
Researchers measured a signal in skull bone using a scan. The signal was higher in people with secondary progressive MS than in people with relapsing-remitting MS or without MS. People with relapsing-remitting MS and people without MS did not show a clear difference. A higher skull signal was linked to greater disability, less brain tissue, and lower scores on a thinking test. The link with disability remained after researchers accounted for several other brain scan findings.
Who Should Care and Why
The study included people with relapsing-remitting MS, people with secondary progressive MS, and people without MS. The strongest group difference appeared in secondary progressive MS. The skull signal was also linked to disability across the MS groups. This finding may interest people tracking how MS changes over time. Researchers suggested the signal might become a way to track disease, but did not test it for that use.
Important Considerations
The study scanned 65 people with MS and 26 people without MS; it did not test a treatment. The findings show links, not whether changes in skull bone cause disability. The abstract does not show whether this scan can predict how your MS will change.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
11/1/2026
Learn how brain support cells may affect inflammation in MS, why their roles can change, and what th
Read More
11/1/2026
A study of 323 people with MS links blood chemicals to walking, thinking, and changes. Learn why the
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.